Development and validation of a prediction model for invasive bacterial infections in febrile children at European Emergency Departments: MOFICHE, a prospective observational study

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3029682 21 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Development and validation of a prediction model for invasive bacterial
infections in febrile children at European Emergency Departments:
MOFICHE, a prospective observational study
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Objectives To develop and cross-validate a multivariable clinical
prediction model to identify invasive bacterial infections (IBI) and to
identify patient groups who might benefit from new biomarkers. Design
Prospective observational study. Setting 12 emergency departments (EDs)
in 8 European countries. Patients Febrile children aged 0-18 years. Main
outcome measures IBI, defined as bacteraemia, meningitis and bone/joint
infection. We derived and cross-validated a model for IBI using
variables from the Feverkidstool (clinical symptoms, C reactive
protein), neurological signs, non-blanching rash and comorbidity. We
assessed discrimination (area under the receiver operating curve) and
diagnostic performance at different risk thresholds for IBI:
sensitivity, specificity, negative and positive likelihood ratios (LRs).
Results Of 16 268 patients, 135 (0.8%) had an IBI. The discriminative
ability of the model was 0.84 (95% CI 0.81 to 0.88) and 0.78 (95% CI
0.74 to 0.82) in pooled cross-validations. The model performed well for
the rule-out threshold of 0.1% (sensitivity 0.97 (95% CI 0.93 to
0.99), negative LR 0.1 (95% CI 0.0 to 0.2) and for the rule-in
threshold of 2.0% (specificity 0.94 (95% CI 0.94 to 0.95), positive LR
8.4 (95% CI 6.9 to 10.0)). The intermediate thresholds of 0.1%-2.0%
performed poorly (ranges: sensitivity 0.59-0.93, negative LR 0.14-0.57,
specificity 0.52-0.88, positive LR 1.9-4.8) and comprised 9784 patients
(60%). Conclusions The rule-out threshold of this model has potential
to reduce antibiotic treatment while the rule-in threshold could be used
to target treatment in febrile children at the ED. In more than half of
patients at intermediate risk, sensitive biomarkers could improve
identification of IBI and potentially reduce unnecessary antibiotic
prescriptions.
Έτος δημοσίευσης:
2021
Συγγραφείς:
Hagedoorn, Nienke N.
Borensztajn, Dorine
Nijman, Ruud Gerard and
Nieboer, Daan
Herberg, Jethro Adam
Balode, Anda
von Both,
Ulrich
Carrol, Enitan
Eleftheriou, Irini
Emonts, Marieke and
van der Flier, Michiel
de Groot, Ronald
Kohlmaier, Benno and
Lim, Emma
Maconochie, Ian
Martinon-Torres, Federico
Pokorn,
Marko
Strle, Franc
Tsolia, Maria
Zavadska, Dace
Zenz,
Werner
Levin, Michael
Vermont, Clementien
Moll, Henriette A.
Περιοδικό:
Archives of Disease in Childhood
Εκδότης:
BMJ Publishing Group
Τόμος:
106
Αριθμός / τεύχος:
7
Σελίδες:
641-647
Λέξεις-κλειδιά:
epidemiology; therapeutics
Επίσημο URL (Εκδότης):
DOI:
10.1136/archdischild-2020-319794
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.